Search Results 91-100 of 14940 for HCG

  1. Accelerated Vs Standard BEP Chemotherapy For Patients With Intermediate And Poor-risk Metastatic Germ Cell Tumours - Mayo Clinic

    Histologically or cytologically confirmed germ cell tumour (non-seminoma or seminoma); or Exceptionally raised tumour markers (AFP ≥ 1000ng/mL and/or HCG ...

  2. Weight-loss basics

    HCG diet: Is it safe and effective? Hidradenitis suppurativa: Tips for weight-loss success · High-protein diets: Are they safe? Intragastric balloon · Keep the ...

  3. Cellular Immunotherapy In Recipients Of HLA-matched, Living Donor Kidney Transplants - Mayo Clinic

    Women of childbearing potential, including peri-menopausal women, should have a negative serum at Screening andor urine human chorionic gonadotropin (hCG) ...

  4. (VOYAGER) Study Of Avapritinib Vs Regorafenib In Patients With Locally Advanced Unresectable Or Metastatic GIST - Mayo Clinic

    ... hCG) pregnancy test consistent with pregnancy, obtained within 7 days before the randomization. Females with β-hCG values that are within the range for ...

  5. Women's Wellness: 100 years of solutions, comfort and hope

    In between, the Counseller-Masson technique of abdominal & vaginal hysterectomy, Pratt dilators, Symmonds retractor, early studies of serum HCG & Ca125 ...

  6. Melanoma Relatlimab Nivolumab - Clinical Trials

    WOCBP must have a negative serum or urine pregnancy test (minimum sensitivity 25 IU/L or equivalent units of HCG) within 24 hours prior to the start of study ...

  7. Depo-Provera (birth control shot) - Mayo Clinic

    This contraceptive shot given every three months has the hormone progestin to help prevent pregnancy.

  8. Breast cancer - Doctors and departments - Mayo Clinic

    Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.

  9. A Multi-center, Open-label Extension, Safety Study Of Mepolizumab In Subjects With Hypereosinophilic Syndrome (HES) From Study 200622 - Mayo Clinic

    About this study. This is an open-label extension study to Study 200622.In this study subjects from Study 200622 will be continued on 4-weekly dosing with ...

  10. A Study To Assess The Efficacy, Safety, Pharmacodynamics, And Pharmacokinetics Of Tazemetostat In Combination With Lenalidomide Plus Rituximab Versus Placebo In Combination With Lenalidomide Plus Rituximab In Adult Patients At Least 18 Years Of Age With Relapsed/Refractory Follicular Lymphoma. - Mayo Clinic

    ... hCG] tests with a minimum sensitivity of 25 mIU/mL or equivalent units of β-hCG) at screening within 10 to 14 days prior to first dose of study drug. The ...